Table 1.
Characteristics | Data, n (%) |
---|---|
| |
NLR | |
<2.0 | 35 (46.1) |
≥2.0 | 41 (53.9) |
CD8+ T-cell | |
<9 | 31 (40.8) |
≥9 | 45 (59.2) |
Age (years) | |
<60 | 56 (73.7) |
≥60 | 20 (26.3) |
Gender | |
Male | 49 (64.5) |
Female | 27 (35.5) |
Distance to anal margin (cm) | |
<5 | 49 (64.5) |
≥5 | 27 (35.5) |
Lymphovascular invasion | |
Yes | 15 (19.7) |
No | 61 (80.3) |
Neural invasion | |
Yes | 14 (18.4) |
No | 62 (81.6) |
Tumor nodules | |
Yes | 16 (21.1) |
No | 60 (78.9) |
Mucinous adenocarcinoma | |
Yes | 8 (10.5) |
No | 68 (89.5) |
T stage | |
T2/3 | 45 (59.2) |
T4 | 31 (40.8) |
N stage | |
N0 | 28 (36.8) |
N1/2 | 48 (63.2) |
TRG | |
1 | 7 (9.2) |
2 | 22 (28.9) |
3 | 16 (21.1) |
4 | 27 (35.5) |
5 | 4 (5.3) |
Radiotherapy | |
Short course | 36 (47.4) |
Long course | 40 (52.6) |
Abbreviations: NLR, neutrophil-to-lymphocyte ratio; TRG, tumor regression grade.